Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMDA
4176
Omada Health Inc
OMDA
$1.44B
| $234K | ﹤0.01% |
14,850
+1,888
| +15% | +$38.3K |
|
4177
Gran Tierra Energy
GTE
$331M
| $234K | ﹤0.01% |
55,239
| – | – |
|
4178
908 Devices
MASS
$414M
| $234K | ﹤0.01% |
44,528
+5,943
| +15% | +$41.5K |
|
4179
Priority Technology Holdings
PRTH
$427M
| $233K | ﹤0.01% |
42,703
+7,013
| +20% | +$43.4K |
|
|
TSSI
4180
TSS Inc
TSSI
$340M
| $233K | ﹤0.01% |
32,917
+6,621
| +25% | +$85.6K |
|
4181
State Street SPDR S&P China ETF
GXC
$474M
| $232K | ﹤0.01% |
2,400
| – | – |
|
|
SBDS
4182
DELISTED
Solo Brands Inc
SBDS
| $232K | ﹤0.01% |
38,297
| – | – |
|
4183
Pioneer Bancorp
PBFS
$419M
| $231K | ﹤0.01% |
17,139
-1,013
| -6% | -$13.6K |
|
4184
Outdoor Holding Co
POWW
$267M
| $231K | ﹤0.01% |
135,012
+12,952
| +11% | +$22.3K |
|
|
SEG
4185
Seaport Entertainment Group
SEG
$373M
| $231K | ﹤0.01% |
11,666
+1,075
| +10% | +$24.1K |
|
|
GPMT
4186
Granite Point Mortgage Trust
GPMT
$58.8M
| $230K | ﹤0.01% |
95,931
+50,747
| +112% | +$136K |
|
4187
Getty Images
GETY
$124M
| $230K | ﹤0.01% |
171,777
+16,347
| +11% | +$28.1K |
|
4188
X4 Pharmaceuticals
XFOR
$425M
| $230K | ﹤0.01% |
+57,500
| New | +$209K |
|
4189
Brookfield Infrastructure Partners
BIP
$18.2B
| $229K | ﹤0.01% |
6,599
+6,300
| +2,107% | +$219K |
|
4190
Icahn Enterprises
IEP
$5.33B
| $228K | ﹤0.01% |
30,205
+637
| +2% | +$5.13K |
|
|
FFAI
4191
Faraday Future Intelligent Electric
FFAI
$9.79M
| $228K | ﹤0.01% |
1,488
+122
| +9% | +$22.7K |
|
4192
InfuSystem Holdings
INFU
$244M
| $227K | ﹤0.01% |
25,312
+13,207
| +109% | +$126K |
|
4193
HighPeak Energy
HPK
$912M
| $227K | ﹤0.01% |
47,888
-15,003
| -24% | -$90.2K |
|
4194
Canadian Solar
CSIQ
$1.07B
| $225K | ﹤0.01% |
9,471
-6,127
| -39% | -$134K |
|
|
LAR
4195
Lithium Argentina AG
LAR
$1.12B
| $224K | ﹤0.01% |
40,215
-38,944
| -49% | -$185K |
|
4196
Bakkt Inc
BKKT
$336M
| $224K | ﹤0.01% |
22,345
+6,774
| +44% | +$150K |
|
4197
CALL
Sumitomo Mitsui Financial
SMFG
$166B
| $224K | ﹤0.01% |
+11,600
| New | +$201K |
|
4198
Lexicon Pharmaceuticals
LXRX
$1.05B
| $224K | ﹤0.01% |
194,743
+162,881
| +511% | +$224K |
|
4199
Virgin Galactic
SPCE
$500M
| $222K | ﹤0.01% |
69,229
+68,466
| +8,973% | +$258K |
|
4200
Hain Celestial
HAIN
$52.9M
| $221K | ﹤0.01% |
206,540
-1,666
| -0.8% | -$2.06K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.